Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplantation Lymphoproliferative Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02440464
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 57
Testing effectiveness (Phase 2)Ended earlyNCT04635735
What this trial is testing

Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00084747
What this trial is testing

Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Early research (Phase 1)Study completedNCT02264873
What this trial is testing

Phase I, Dose Escalation Study of Decitabine

Who this might be right for
Leukemia, Lymphoblastic, AcuteLeukemia, Myeloid AcuteHematopoetic Myelodysplasia
University of Florida 3
Testing effectiveness (Phase 2)Study completedNCT01208896
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma

Who this might be right for
Lymphoma, FollicularStem Cell Transplantation
University Hospital, Bordeaux 32
Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05982275
What this trial is testing

Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant

Who this might be right for
Multiple MyelomaAllogeneic Stem Cell Transplantation
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 25
Not applicableStudy completedNCT05818644
What this trial is testing

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

Who this might be right for
Hepatic Artery ThrombosisHepatic Artery StenosisPediatric ALL+1 more
University Medical Center Groningen 583
Testing effectiveness (Phase 2)WithdrawnNCT00621036
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+1 more
University of Texas Southwestern Medical Center
Not applicableStudy completedNCT04760184
What this trial is testing

Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden

Who this might be right for
Covid19Myeloma MultipleMalignant Lymphoma+2 more
Uppsala University 20
Not applicableStudy completedNCT02300961
What this trial is testing

Feasibility Neurocognitive Outcome After Transplant

Who this might be right for
Stem Cell TransplantationPediatric CancerAcute Lymphoblastic Leukemia
Stanford University 17
Testing effectiveness (Phase 2)Study completedNCT00096161
What this trial is testing

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Fred Hutchinson Cancer Center 36
Early research (Phase 1)Looking for participantsNCT07280494
What this trial is testing

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

Who this might be right for
CD7+ T-ALL/LBL
Peking University People's Hospital 18
Not applicableLooking for participantsNCT07479927
What this trial is testing

Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy

Who this might be right for
Acute Lymphoblastic Leukemia
Hospital Universitario La Paz 40
Testing effectiveness (Phase 2)Study completedNCT00058305
What this trial is testing

Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+9 more
National Cancer Institute (NCI) 28
Large-scale testing (Phase 3)Study completedNCT00784537
What this trial is testing

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

Who this might be right for
Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS 520
Testing effectiveness (Phase 2)Study completedNCT00750659
What this trial is testing

Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation
Sheba Medical Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT07356245
What this trial is testing

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Who this might be right for
T-cell LymphomaGraft Versus Host DiseaseLymphoma, T-Cell+5 more
Jonathan Brammer 44
Large-scale testing (Phase 3)Ended earlyNCT01103388
What this trial is testing

Rituximab Maintenance After Autologous Transplantation

Who this might be right for
Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center 4
Next Page